Frontlight ResearchEarly access
Trial site
Saint Petersburg
- 2running trials
- 4closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis3 trials
- Asthma1 trial
- Atopic dermatitis (eczema)1 trial
- COPD1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Sanofi6 trials
Running trials
Active, not recruiting
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Active, not recruiting
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026